341 related articles for article (PubMed ID: 30666443)
1. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
2. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
[TBL] [Abstract][Full Text] [Related]
3. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
[TBL] [Abstract][Full Text] [Related]
4. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
[TBL] [Abstract][Full Text] [Related]
5. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
[TBL] [Abstract][Full Text] [Related]
6. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
Chen D; Ma Y; Wang X; Yu S; Li L; Dai B; Mao Z; Sun L; Xu C; Rong S; Tang M; Zhao H; Liu H; Serra AL; Graf N; Liu S; Wüthrich RP; Mei C
PLoS One; 2014; 9(3):e92232. PubMed ID: 24651850
[TBL] [Abstract][Full Text] [Related]
8. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
9. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
[TBL] [Abstract][Full Text] [Related]
11. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
[TBL] [Abstract][Full Text] [Related]
12. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
13. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
14. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT; Torres VE
Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).
Uchiyama K; Mochizuki T; Shimada Y; Nishio S; Kataoka H; Mitobe M; Tsuchiya K; Hanaoka K; Ubara Y; Suwabe T; Sekine A; Nutahara K; Tsuruya K; Ishimura E; Nakatani S; Sofue T; Tanaka S; Narita I; Maruyama S; Horie S; Muto S
Clin Exp Nephrol; 2021 Sep; 25(9):970-980. PubMed ID: 33928479
[TBL] [Abstract][Full Text] [Related]
16. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
[TBL] [Abstract][Full Text] [Related]
17. Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements.
Jagtap JM; Gregory AV; Homes HL; Wright DE; Edwards ME; Akkus Z; Erickson BJ; Kline TL
Abdom Radiol (NY); 2022 Jul; 47(7):2408-2419. PubMed ID: 35476147
[TBL] [Abstract][Full Text] [Related]
18. Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease.
Horie S; Muto S; Kawano H; Okada T; Shibasaki Y; Nakajima K; Ibuki T
Clin Exp Nephrol; 2021 May; 25(5):467-478. PubMed ID: 33471240
[TBL] [Abstract][Full Text] [Related]
19. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
20. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
